Elevance Health (NYSE:ELV – Get Free Report) and Selectis Health (OTCMKTS:GBCS – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.
Risk & Volatility
Elevance Health has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Selectis Health has a beta of -1.03, meaning that its stock price is 203% less volatile than the S&P 500.
Profitability
This table compares Elevance Health and Selectis Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elevance Health | 2.84% | 15.59% | 5.60% |
| Selectis Health | -1.87% | N/A | -2.34% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elevance Health | $199.13 billion | 0.32 | $5.66 billion | $25.12 | 11.67 |
| Selectis Health | $39.49 million | 0.33 | -$2.42 million | ($0.27) | -15.56 |
Elevance Health has higher revenue and earnings than Selectis Health. Selectis Health is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
89.2% of Elevance Health shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 15.2% of Selectis Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent recommendations for Elevance Health and Selectis Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elevance Health | 1 | 9 | 12 | 0 | 2.50 |
| Selectis Health | 0 | 0 | 0 | 0 | 0.00 |
Elevance Health currently has a consensus price target of $387.40, suggesting a potential upside of 32.17%. Given Elevance Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Elevance Health is more favorable than Selectis Health.
Summary
Elevance Health beats Selectis Health on 12 of the 14 factors compared between the two stocks.
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.
